Skip to main content
Clinical Trials/ACTRN12622000072718
ACTRN12622000072718Completed未知

Patient-Focused Prognostic Tool to Evaluate Willingness for Surgery in Total Knee Arthroplasty: A Randomised Controlled Trial (The Proto Knee Trial)

The University Of Melbourne0 sites213 target enrollmentStarted: January 21, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
213

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Diagnosis
Masking
Blinded (masking used)

Eligibility Criteria

Ages
45 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Diagnosed with knee OA and are considering TKA
  • Considering primary and unilateral TKA
  • Have already trialled non-operative management for their knee symptoms
  • Are willing and able to use web or mobile phone based prognostic tool interfaces
  • Able to provide informed consent to participate and be followed up for the entire
  • duration of the study

Exclusion Criteria

  • Source of knee symptoms is considered to be from any cause other than knee OA e.g.
  • rheumatoid arthritis, hip osteoarthritis, referred lower back pain etc.
  • Are considering bilateral TKA, revision TKA, unicondylar knee arthroplasty (UKA),
  • or patellofemoral arthroplasty (PFA)
  • Unwilling to consider TKA despite being advised by the Orthopaedic Surgeon this
  • would be a reasonable management option for their knee symptoms
  • Prior history of septic arthritis in the affect knee
  • Significant bilateral knee symptoms
  • Intra-articular injection in the affected knee within the last 3 months

Investigators

Similar Trials

Patient-Focused Prognostic Tool to... | Clinical Trial